| 471 |
THE INFLUENCE OF NEONATAL BCG VACCIN ON TUBERCULIN
SKIN TEST REACTIVITY IN PRIMARY SCHOOL CHILDREN
|
2006 |
| 472 |
TRANSFORMING GROWTH FACTOR P AND OTHER ANGIOGENIC
FACTORS IN HEMATOLOGIC MALIGNANCIES OF CHILDHD
|
2006 |
| 473 |
TRANSFORMING GROWTH FACTOR P AND OTHER ANGIOGENIC
FACTORS IN HEMATOLOGIC MALIGNANCIES OF CHILDHD
|
2006 |
| 474 |
TRANSFORMING GROWTH FACTOR P AND OTHER ANGIOGENIC
FACTORS IN HEMATOLOGIC MALIGNANCIES OF CHILDHD
|
2006 |
| 475 |
VALUE OF SERUM PROLACTIN IN EPILEPTIC AND SOME NON-EPILEPTIC EVENTS |
2006 |
| 476 |
Clinical, virological and Echocardiographic study in children with dilated cardiomyopathy. |
2005 |
| 477 |
Clinical, virological and Echocardiographic study in children with dilated cardiomyopathy. |
2005 |
| 478 |
Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense? American Journal of Therapeutics 2005;12: 320-7. |
2005 |
| 479 |
Immunohistochemical Evaluation Of P53 Expression In Astrocytomas. |
2005 |
| 480 |
Lamellar body count as a predictor of neonatal lung maturity in high-risk pregnancies |
2005 |